Efficacy and Safety of Apatinib Treatment for Patients with Advanced Intrahepatic Cholangiocarcinoma

por Lin, Guohe, Wang, Bicheng, Wu, Xiuwei, Sun, Tong, Chen, Lili, Lu, Canliang, Wang, Nianfei
Publicado 2020

Elevated neutrophil-to-lymphocyte ratio is an independent poor prognostic factor in patients with intrahepatic cholangiocarcinoma

por Lin, Guohe, Liu, Yongcheng, Li, Shuhong, Mao, Yize, Wang, Jun, Shuang, Zeyu, Chen, Jianlin, Li, Shengping
Publicado 2016

Alpha-L-Fucosidase Serves as a Prognostic Indicator for Intrahepatic Cholangiocarcinoma and Inhibits Its Invasion Capacity

por Shuang, Zeyu, Mao, Yize, Lin, Guohe, Wang, Jun, Huang, Xin, Chen, Jianlin, Duan, Fangting, Li, Shengping
Publicado 2018

PARP inhibitor olaparib sensitizes cholangiocarcinoma cells to radiation

por Mao, Yize, Huang, Xin, Shuang, Zeyu, Lin, Guohe, Wang, Jun, Duan, Fangting, Chen, Jianlin, Li, Shengping
Publicado 2018